Characterisation of the adiponectin receptors: The non-conserved N-terminal region of AdipoR2 prevents its expression at the cell-surface

Biochemical and Biophysical Research Communications

Volumn 432, Issue 1, 2013, Pages 28-33

  Keshvari, Sahar ^a   Rose, Felicity J ^a   Charlton, Hayley K ^a   Scheiber, Nicole L ^b   Webster, Julie ^a   Kim, Yu Hee ^a   Ng, Choaping ^a   Parton, Robert G ^b   Whitehead, Jonathan P ^a  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adipokine; AdipoR; Cell surface expression; PAQR; Seven transmembrane receptor

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; HETERODIMER; OLIGOMER;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MEMBRANE; CELL SURFACE; CHIMERA; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ADIPONECTIN; RECOMBINANT FUSION PROTEINS;

EID: 84875366042     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.092     Document Type: Article

References (31)

1. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
2. Hickman I.J., Whitehead J.P. Structure, signalling and physiologic role of adiponectin - dietary and exercise-related variations. Curr. Med. Chem. 2012.
3. Gu W., Li Y. The therapeutic potential of the adiponectin pathway. BioDrugs 2012, 26:1-8.
4. Tang Y.T., Hu T., Arterburn M., Boyle B., Bright J.M., Emtage P.C., Funk W.D. PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J. Mol. Evol. 2005, 61:372-380.
5. Holland W.L., Miller R.A., Wang Z.V., Sun K., Barth B.M., Bui H.H., Davis K.E., Bikman B.T., Halberg N., Rutkowski J.M., Wade M.R., Tenorio V.M., Kuo M.S., Brozinick J.T., Zhang B.B., Birnbaum M.J., Summers S.A., Scherer P.E. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 2011, 17:55-63.
6. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada-Iwabu M., Kawamoto S., Kubota N., Kubota T., Ito Y., Kamon J., Tsuchida A., Kumagai K., Kozono H., Hada Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Awazawa M., Takamoto I., Froguel P., Hara K., Tobe K., Nagai R., Ueki K., Kadowaki T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 2007, 13:332-339.
7. Bjursell M., Ahnmark A., Bohlooly-Y M., William-Olsson L., Rhedin M., Peng X.-R., Ploj K., Gerdin A.-K., Arnerup G., Elmgren A., Berg A.-L., Oscarsson J., Linden D. Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 2007, 56:583-593.
8. Liu Y., Michael M.D., Kash S., Bensch W.R., Monia B.P., Murray S.F., Otto K.A., Syed S.K., Bhanot S., Sloop K.W., Sullivan J.M., Reifel-Miller A. Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 2007, 148:683-692.
9. Milligan G. A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br. J. Pharmacol. 2008, 153(Suppl. 1):S216-S229.
10. Lee M.H., Klein R.L., El-Shewy H.M., Luttrell D.K., Luttrell L.M. The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry 2008, 47:11682-11692.
11. Kosel D., Heiker J.T., Juhl C., Wottawah C.M., Bluher M., Morl K., Beck-Sickinger A.G. Dimerization of adiponectin receptor 1 is inhibited by adiponectin. J. Cell Sci. 2010, 123:1320-1328.
12. Juhl C., Kosel D., Beck-Sickinger A.G. Two motifs with different function regulate the anterograde transport of the adiponectin receptor 1. Cell. Signal. 2012.
13. Buechler C., Wanninger J., Neumeier M. Adiponectin receptor binding proteins-recent advances in elucidating adiponectin signalling pathways. FEBS Lett. 2010, 584:4280-4286.
14. Mao X., Kikani C.K., Riojas R.A., Langlais P., Wang L., Ramos F.J., Fang Q., Christ-Roberts C.Y., Hong J.Y., Kim R.Y., Liu F., Dong L.Q. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 2006, 8:516-523.
15. Deepa S.S., Dong L.Q. APPL1: role in the adiponectin signaling and beyond. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E22-E36.
16. Charlton H.K., Webster J., Kruger S., Simpson F., Richards A.A., Whitehead J.P. ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling. Biochem. Biophys. Res. Commun. 2010, 392:234-239.
17. Richards A.A., Stephens T., Charlton H.K., Jones A., Macdonald G.A., Prins J.B., Whitehead J.P. Adiponectin multimerisation is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerisation by alterations in post-translational modifications. Mol. Endocrinol. 2006, 20:1673-1687.
18. Thomas E.C., Gunter J.H., Webster J.A., Schieber N.L., Oorschot V., Parton R.G., Whitehead J.P. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms. PLoS ONE 2012, 7:e51096.
19. Heiker J.T., Kosel D., Beck-Sickinger A.G. Molecular advances of adiponectin and adiponectin receptors. Biol. Chem. 2010, 391:1005-1018.
20. Kupchak B.R., Garitaonandia I., Villa N.Y., Smith J.L., Lyons T.J. Antagonism of human adiponectin receptors and their membrane progesterone receptor paralogs by TNFalpha and a ceramidase inhibitor. Biochemistry 2009, 48:5504-5506.
21. Garitaonandia I., Smith J.L., Kupchak B.R., Lyons T.J. Adiponectin identified as an agonist for PAQR3/RKTG using a yeast-based assay system. J. Recept. Signal Transduct. Res. 2009, 29:67-73.
22. Feng L., Xie X., Ding Q., Luo X., He J., Fan F., Liu W., Wang Z., Chen Y. Spatial regulation of Raf kinase signaling by RKTG. Proc. Natl. Acad. Sci. USA 2007, 104:14348-14353.
23. Luo X., Feng L., Jiang X., Xiao F., Wang Z., Feng G.S., Chen Y. Characterization of the topology and functional domains of RKTG. Biochem. J. 2008, 414:399-406.
24. Ding Q., Wang Z., Chen Y. Endocytosis of adiponectin receptor 1 through a clathrin- and Rab5-dependent pathway. Cell Res. 2009, 19:317-327.
25. Ritter S.L., Hall R.A. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat. Rev. Mol. Cell Biol. 2009, 10:819-830.
26. Rozenfeld R., Devi L.A. Exploring a role for heteromerization in GPCR signalling specificity. Biochem. J. 2010, 433:11-18.
27. Tsuchida A., Yamauchi T., Ito Y., Hada Y., Maki T., Takekawa S., Kamon J., Kobayashi M., Suzuki R., Hara K., Kubota N., Terauchi Y., Froguel P., Nakae J., Kasuga M., Accili D., Tobe K., Ueki K., Nagai R., Kadowaki T. Insulin/foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem. 2004, 279:30817-30822.
28. Iwabu M., Yamauchi T., Okada-Iwabu M., Sato K., Nakagawa T., Funata M., Yamaguchi M., Namiki S., Nakayama R., Tabata M., Ogata H., Kubota N., Takamoto I., Hayashi Y.K., Yamauchi N., Waki H., Fukayama M., Nishino I., Tokuyama K., Ueki K., Oike Y., Ishii S., Hirose K., Shimizu T., Touhara K., Kadowaki T. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010, 464:1313-1319.
29. Tomita K., Oike Y., Teratani T., Taguchi T., Noguchi M., Suzuki T., Mizutani A., Yokoyama H., Irie R., Sumimoto H., Takayanagi A., Miyashita K., Akao M., Tabata M., Tamiya G., Ohkura T., Hibi T. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology 2008, 48:458-473.
30. Tian L., Luo N., Zhu X., Chung B.H., Garvey W.T., Fu Y. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Atherosclerosis 2012, 221:66-75.
31. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol. Rev. 2009, 89:1025-1078.